Aspirin dosage in the acute coronary syndrome
Keywords:
aspirin doses, prevention, cardiovascular disease.Abstract
Background: Few clinical trials have been published proving the cardiovascular disease secondary prevention. We presented a review of the recently published literature on the aspirin dosage in patients with acute coronary syndrome.Outcomes: Well documented clinical trials assessing the comparative efficacy of different aspirin doses are very scarce in the international literature.
Discussion: this complex anti-platelet therapy makes very difficult identifying the exact aspirin doses for achieving the best results with efficacy and minimizing the risk of adverse events, answering to several norms and recommendations.
Conclussions: In spite of this fact, current evidence suggests that the aspirin doses of 75-100 mg/day offers an optimal benefit/risk proportion in patients with acute coronary syndrome.
Downloads
Download data is not yet available.
Published
2015-07-09
How to Cite
1.
Arredondo Bruce AE, Acuña Sobrino JA, Arredondo Rubido AE. Aspirin dosage in the acute coronary syndrome. Rev Méd Electrón [Internet]. 2015 Jul. 9 [cited 2025 Jan. 9];37(4):364-73. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/1334
Issue
Section
Review article
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
